Ter Meer Steinmeister & Partner patent opposition analysis

The comprehensive analysis of Ter Meer Steinmeister & Partner opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Ter Meer Steinmeister & Partner

Patent NumberTitleApplicantOpposition DateOpposition Company
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 18, 2025GENERICS UK
Motor Vehicle PartsHP PELZER HOLDINGSep 10, 2025AECHTER
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 3, 2025SANDOZ
Methods Of Enhancing And/Or Stabilizing Cardiac Function In Patients With Fabry DiseaseAMICUS THERAPEUTICSSep 3, 2025SANDOZ
Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry DiseaseAMICUS THERAPEUTICSAug 13, 2025SANDOZ
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 7, 2025GENERICS UK
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 8, 2025RUMI
Process Of Spray Drying Of Glp-1 PeptideNOVO NORDISKJun 11, 2025GENERICS UK
Aqueous Disinfectant Composition Containing Peracetic AcidSCHLKE & MAYRJun 11, 2025BODE CHEMIE
Methods Of Treating Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSJun 4, 2025SANDOZ